Ambrx Biopharma Inc (DELISTED) (AMAM:DL)
27.99
+0.01
(+0.04%)
USD |
NASDAQ |
Mar 06, 16:00
28.00
+0.01
(+0.04%)
Pre-Market: 20:00
Ambrx Biopharma Accounts Payable (Quarterly): 5.141M for Sept. 30, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 5.141M |
June 30, 2023 | 6.362M |
March 31, 2023 | 7.107M |
December 31, 2022 | 3.205M |
June 30, 2022 | 5.696M |
Date | Value |
---|---|
December 31, 2021 | 5.272M |
June 30, 2021 | 3.768M |
June 30, 2021 | 3.768M |
December 31, 2020 | 2.82M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
2.82M
Minimum
Dec 2020
7.107M
Maximum
Mar 2023
4.793M
Average
5.141M
Median
Sep 2023
Accounts Payable (Quarterly) Benchmarks
Johnson & Johnson | 8.174B |
Axonics Inc | 15.77M |
Harpoon Therapeutics Inc (DELISTED) | 3.435M |
Merck & Co Inc | 3.514B |
RayzeBio inc (DELISTED) | 2.237M |